Antares Pharma, Inc.

Antares Pharma, Inc.

Antares Pharma, Inc.

Overview
Date Founded

2005

Headquarters

100 PRINCETON SOUTH, SUITE 300, EWING, NJ, 08628

Type of Company

Public

Employees (Worldwide)

178

Industries

Medical Products & Equipment
Wholesale: Medical Supplies & Pharmaceuticals
Hospitals & Patient Services

Company Description

Antares Pharma is a revenue-generating product focused specialty pharmaceutical company that has developed three proprietary platforms, two of which now include FDA approved products. Our products typically improve safety and efficacy profiles by minimizing dosing and reducing side effects while improving patient compliance. We focus on self-injection pharmaceutical products and technologies and topical gel -based products. Our subcutaneous injection technology platforms include Vibex™ disposable pressure-assisted auto injectors, Vision® reusable needle-free injectors, and disposable multi-use pen injectors.

Contact Data
Trying to get in touch with decision makers at Antares Pharma, Inc.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

President & Chief Executive Officer

Executive Vice President & Chief Financial Officer

Chief Compliance Officer & Corporate Secretary

Vice President & General Manager, Parenteral Products Division

Senior Vice President, Technology Portfolio & Intellectual Property

Senior Vice President, Regulatory Affairs & Quality Assurance

Senior Vice President, Product Development

Senior Vice President, Corporate Business Development

Senior Vice President of Commercial

Vice President-Communications & Investor Relations

Board of Directors

Founder at InKine Pharmaceutical Co., Inc.

President & Chief Executive Officer at Antares Pharma, Inc.

Founder at Gueth Consulting LLC

Executive Vice President, Chief Medical Officer at Emergent BioSolutions, Inc.

President, Chief Executive Officer & Director at Aurinia Pharmaceuticals, Inc.

Former Director, Public Policy Planning & Development at Eli Lilly & Company

Founder at Robert Roche Associates LLC

Paths to Antares Pharma, Inc.
Potential Connections via
Relationship Science
You
Antares Pharma, Inc.
Owners & Shareholders
Details Hidden

CWM uses different methods of analyses and investment strategies in providing investment advisory services to their clients. The methods of analysis include fundamental analysis; technical analysis; quantitative analysis; qualitative analysis; asset allocation; mutual fund and/or ETF analysis; and sector rotation analysis. Their investment strategies include long-term purchases; short-term purchases; and margin transactions.

Details Hidden

SIG begins the investment process by defining a client’s current situation and long-term investment goals. Their primary investment execution is through individual equity and fixed income securities, mutual funds and ETFs, which are combined into a customized, proprietary asset allocation for each client. The firm may also incorporate alternative and third-party manager’s investments within the client’s asset allocation.

Details Hidden

Oracle Investment Management focuses on long/short investments in the US healthcare sector with an emphasis on pharmaceutical and biotechnology companies. The firm tends to invest in small-cap US companies but they also invest in mid-cap and large-cap companies and in Europe. The firm seeks to achieve strong absolute and risk-adjusted returns on both client and principals capital by anticipating key sub-sector themes and by identifying specific companies within those sub-sectors with unrecognized investment potential. They use fundamental research in their stock selection and maintain a medium turnover rate

Recent Transactions
Details Hidden

Antares Pharma, Inc. issued USD Common Stock

Details Hidden

Antares Pharma, Inc. issued USD Common Stock

Details Hidden

Antares Pharma, Inc. issued USD Common Stock

Insider Transactions
Details Hidden
Transaction Advisors
Auditor

Advised onAntares Pharma, Inc. issued USD Common Stock

Underwriter

Advised onAntares Pharma, Inc. issued USD Common Stock

Underwriter

Advised onAntares Pharma, Inc. issued USD Common Stock

Legal Advisor

Advised onAntares Pharma, Inc. issued USD Common Stock

Managing Director

Advised onAntares Pharma, Inc. issued USD Common Stock

Managing Director

Advised onAntares Pharma, Inc. issued USD Common Stock

Advisors & Consultants
Consultant

Vice President, General Counsel, Secretary & Government Relations at The Wistar Institute

Clients

Pfizer Inc. engages in the discovery, development, and manufacture of healthcare products specializes in medicines, vaccine, and consumer healthcare. It operates through the Pfizer Innovative Health (IH) and Pfizer Essential Health (EH) segments. The IH segment focuses on the development and commercializing medicines and vaccines for internal medicine, oncology, inflammation and immunology, rate disease, and consumer healthcare. The EH segment is involved in development and supply of branded generics, generic sterile injectable products, biosimilars, and select branded products including anti-infectives. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Cardinal Health, Inc. is a healthcare services and products company, which engages in the provision of customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories and physician offices. It also provides medical products and pharmaceuticals and cost-effective solutions that enhance supply chain efficiency. The company operates through the following segments: Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical and over-the-counter healthcare and consumer products. The Medical segment manufactures, sources and distributes cardinal health branded medical, surgical and laboratory products. The company was founded by Robert D. Walter in 1971 and is headquartered in Dublin, OH.

McKesson is dedicated to delivering the vital medicines, medical supplies and information technologies that enable the health care industry to provide patients better, safer care. McKesson is made up of many businesses, all serving the health care industry. Our businesses fall into one of two primary categories: Distribution solutions. We are the largest pharmaceutical distributor in North America, distributing one-third of the medicines used every day. As one of the leading pharmaceutical companies, we supply more than 40,000 U.S. pharmacy locations, from Wal-Mart to the Department of Veterans Affairs to community pharmacies and hospitals. McKesson is also one of the leading medical supply companies and distributes medical-surgical supplies and homecare supplies. Healthcare Technology solutions. We develop and install healthcare information technology systems that eliminate the need for paper prescriptions and paper medical records. Our software and hardware are used in more than 70% of the nation's hospitals with more than 200 beds. Our hospital information system solutions include electronic health record system (EHR) and clinical decision support system such as Interqual. McKesson's Healthcare IT division also serves diverse areas within the health industry by offering solutions such as pharmacy automation and medical claims management software. McKesson publicly traded on NYSE under MCK Businesses Serving our customers—pharmacies, medical and pharmaceutical manufacturers, hospitals, and insurers—as the health care industry evolves is our primary goal. We have business lines to automate processes from medical supplies packaging to claims management, and revenue cycle management to medical imaging. McKesson's long history in pharmaceutical industry History McKesson has a long history in health care. We’ve been a trusted provider of medical supplies and goods for more than 175 years.

Key Stats and Financials As of 2019
Market Capitalization
$488M
Total Enterprise Value
$765M
Earnings Per Share
$-0.01
Revenue
$124M
EBITDAMargin
2.87%
EBITDA
$3.55M
Net Profit
$-2.03M
Enterprise Value / Sales
6.18x
TEVNet Income
-377.63x
Debt TEV
0.06x
Total Debt
$47.1M
Total Equity
$54.5M
Three Year Compounded Annual Growth Rate Of Revenue
33.36%
Enterprise Value EBITDAOperating
213.8x
Suppliers
Uman Pharma, Inc. Pharmaceuticals | Montréal, Canada

Uman Pharma, Inc. develops, manufactures, and markets generic injectable pharmaceutical products. The company was founded in December 20, 2007 and is headquartered in Montreal, Canada.

Cardinal Health, Inc. Pharmaceuticals | Dublin, OH

Cardinal Health, Inc. is a healthcare services and products company, which engages in the provision of customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories and physician offices. It also provides medical products and pharmaceuticals and cost-effective solutions that enhance supply chain efficiency. The company operates through the following segments: Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical and over-the-counter healthcare and consumer products. The Medical segment manufactures, sources and distributes cardinal health branded medical, surgical and laboratory products. The company was founded by Robert D. Walter in 1971 and is headquartered in Dublin, OH.

Jabil, Inc. Industrial Machinery & Manufacturing | St. Petersburg, FL

Jabil, Inc. engages in the provision of electronic manufacturing services and solutions. It offers electronics design, production, product management, and repair services to companies in the automotive and transportation, capital equipment, consumer lifestyles and wearable technologies, computing and storage, defense and aerospace, digital home, healthcare, industrial and energy, mobility, networking and telecommunications, packaging, point of sale, and printing industries. The firm operates through the following segments: Electronics Manufacturing Services and Diversified Manufacturing Services. The Electronics Manufacturing Services segment focuses around leveraging IT; supply chain design and engineering; and technologies largely centered on core electronics. The Diversified Manufacturing Services segment provides engineering solutions, with an emphasis on material sciences and technologies. The company was founded by William E. Morean and James Golden in 1966 and is headquartered in St. Petersburg, FL.

Competitors
Sun Pharmaceutical Industries Ltd. Pharmaceuticals - Mumbai, India

Sun Pharmaceutical We are an international speciality pharma company, with a large presence in the US and India, and a footprint across 41 other markets. In the US, which is our largest market, we have built a strong pipeline of generics, directly and through our subsidiaries Caraco and Sun Pharmaceutical Inc. Taro adds strong dermatology range to this portfolio. In India and rest of the world markets, our brands are prescribed in chronic therapy areas like cardiology, psychiatry, neurology, diabetology, ophthalmology, orthopedics etc. We are market leaders in speciality therapy areas in India. We retain the drive for growth that marked our early days, when we had. begun in 1983 with just 5 products. Since then, we have crossed several milestones to emerge as a leading pharma company in India where we are the 5th largest by prescription sales, a rank that we have retained over a decade. (IMS ORG Stockist Audit, March. 2012) Since the mid- nineties, we have used a combination of growth and acquisition to drive growth. important acquisitions have included those of the US, detroit-based Caraco Parma Labs and a plant at Halol which now holds UKMHRA and USFDA approvals. The 2010 acquisition of Taro Pharmaceuticals doubles our US business and brings us strengths in dermatology and pediatrics

Perrigo Co. Plc Pharmaceuticals - Dublin, Ireland

Perrigo Co. Plc engages in providing over-the-counter (OTC) self-care and wellness solutions. Its solutions enhance individual well-being by empowering consumers to proactively prevent or treat conditions that can be self-managed. The firm operates through three segments: Consumer Self-Care Americas, Consumer Self-Care International, and Prescription Pharmaceuticals. The Consumer Self-Care Americas segment comprises the store brand consumer self-care business in the U.S., Mexico and Canada. The Consumer Self-Care International segment includes the branded consumer self-care business in Europe, along with consumer-focused businesses in the U.K. and Australia. The Prescription Pharmaceuticals commercializes and manufactures generic prescription products in the U.S. and diagnostic products in Israel. The company was founded by Luther Perrigo in 1887 and is headquartered in Dublin, Ireland.

GlaxoSmithKline Plc Pharmaceuticals - Brentford, Gbr

GlaxoSmithKline Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the following segments: Pharmaceuticals, Vaccines, Consumer Healthcare, and Corporate Executive Team (CET). The Pharmaceuticals segment focuses on developing medicines in respiratory and infectious diseases, oncology, and immuno-inflammation. The Vaccines segment produces pediatric and adult vaccines to prevent a range of infectious diseases including, hepatitis A and B, diphtheria, tetanus and whooping cough, measles, mumps and rubella, polio, typhoid, influenza, and bacterial meningitis. The Consumer Healthcare segment develops and markets brands in the oral health, pain relief, respiratory, nutrition and gastro intestinal, and skin health categories. The CET segment refers to the management of business activities. The company was founded in 1715 and is headquartered in Middlesex, the United Kingdom.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Antares Pharma, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Antares Pharma, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Antares Pharma, Inc..